Conclusion
Control of tumour cell growth through perturbation of cellular iron metabolism is a potentially important strategy in the treatment of cancer and thus warrants continued investigation. The Ferric-sorbitol-citrate (Jectofer) and tested ferrocenes are very interesting in that fields because of their specific antitumour effect and they could be further tested and submitted as a new antitumour substances.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Poljak-Blazi, M., Vidovic, A.F., Rapic, V., Škare, D. (2002). Antiproliferative Ability of Ferric-Sorbitol-Citrate and Ferrocenes for Malignant Cell Line, Hep2 and F10. In: Roussel, A.M., Anderson, R.A., Favier, A.E. (eds) Trace Elements in Man and Animals 10. Springer, New York, NY. https://doi.org/10.1007/0-306-47466-2_29
Download citation
DOI: https://doi.org/10.1007/0-306-47466-2_29
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-306-46378-5
Online ISBN: 978-0-306-47466-8
eBook Packages: Springer Book Archive